Eiichiro Uchino Selected Research

Eiichiro Uchino Research Topics

2	Neoplasms (Cancer) 02/2024 - 01/2024
2	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 11/2022
2	Fibrosis (Cirrhosis) 12/2020 - 01/2019
1	Proteinuria 02/2024
1	Disease Progression 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2022
1	Peptic Ulcer (Peptic Ulcers) 11/2022
1	Dyspepsia (Indigestion) 11/2022
1	Myocardial Infarction 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 09/2021
1	Hypertension (High Blood Pressure) 03/2021
1	Inflammation (Inflammations) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Kidney Diseases (Kidney Disease) 12/2020
1	Ischemia 12/2020
1	Hypothermia 12/2020
1	Sclerosis 01/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2018
1	Microscopic Polyangiitis 05/2017
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2017
1	Glomerulonephritis 05/2017
1	Vasculitis (Vasculitides) 05/2017

3	AntibodiesIBA 02/2024 - 05/2017
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	GlucocorticoidsIBA 05/2018 - 05/2017
1	Bevacizumab (Avastin)FDA Link 02/2024
1	Endothelial Growth FactorsIBA 02/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	MacrolidesIBA 11/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	Proton Pump InhibitorsIBA 11/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2021
1	Hematoxylin (Haematoxylon)IBA 09/2021
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Methenamine (Hexamine)IBA 01/2020
1	Periodic AcidIBA 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Phospholipase A2 ReceptorsIBA 05/2018
1	Myeloblastin (Proteinase 3)IBA 05/2017
1	Peroxidase (Myeloperoxidase)IBA 05/2017
1	Immunoglobulin G (IgG)IBA 05/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2017
1	antiglomerular basement membrane antibodyIBA 05/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2017

5	Therapeutics 01/2024 - 05/2017
1	Precision Medicine 01/2023
1	Percutaneous Coronary Intervention 01/2022
1	Plasma Exchange 05/2017
1	Remission Induction 05/2017